Head to head
Hims vs Henry Meds
These two are not the same purchase. Henry Meds supplies compounded medication; Hims supplies FDA-approved drugs only. Everything below is from the record, and every regulatory action links to its document.
- Hims
- FDA-approved
$149/mo - Henry Meds
- Compounded
$179/mo - Hims on file
- 5
- Henry Meds on file
- 2
Side by side
What each one publishes about itself
Every figure here is the provider’s own advertised number, not an estimate. A dash means the company does not publish it.
| Hims | Henry Meds | |
|---|---|---|
| Supplies | FDA-approved medication only | Compounded only |
| Advertised from | $149/mo | $179/mo |
| First month | $39 | — |
| Medication in the price | Billed separately | Included |
| Insurance | Cash pay | Cash pay |
| Intake | Async | Async |
| On the record | 5 actions | 2 actions |
The difference that actually matters
Henry Meds supplies compounded semaglutide or tirzepatide — medication prepared by a compounding pharmacy, not an FDA-approved product. Cheaper, legal, and the category the FDA has been issuing warning letters about.
Hims supplies the approved drugs and nothing else, which puts it outside the compounding enforcement entirely — and is a large part of why it costs what it costs.
What is on Hims’s record
2025-09
FDA warning letter to Hims & Hers Health, Inc. dba Hims (MARCS-CMS 716567) over compounded GLP-1 marketing.
2025-06
Novo Nordisk terminated its collaboration with Hims & Hers, alleging illegal sham compounding and Chinese-sourced unapproved API.
2026-03
Novo Nordisk patent infringement suit filed February 2026 was dropped 9 March 2026 under a settlement in which Hims agreed to stop promoting compounded GLP-1s.
What is on Henry Meds’s record
2025-04
Eli Lilly sued Henry Meds (N.D. Cal.) over unauthorized tirzepatide copies, in the same four-defendant action that named Mochi Health, Fella Health/Delilah and Willow Health Services.
BBB rating F, not accredited, with 232 complaints of which 26 unanswered; BBB states concerns primarily involve billing, cancellation and fulfillment issues.
Go direct
Both companies, and what we earn from each
We do not recommend one over the other. Where a link pays us, it says so here and on the provider’s own page.
Hims
FDA-approved medication only, from $149 a month. 5 actions on record, each linked on its page. The link below earns us nothing.
Henry Meds
Compounded only, from $179 a month. 2 actions on record, each linked on its page. The link below earns us nothing.
Straight answers
Hims vs Henry Meds, in short
- Is Hims or Henry Meds cheaper?
- Hims advertises the lower starting price — $149 a month against $179. Whether that is the cheaper purchase depends on what each figure covers: Hims bills medication separately, and Henry Meds includes it.
- What is the difference between Hims and Henry Meds?
- The one that matters: Henry Meds supplies compounded medication — prepared by a compounding pharmacy, not an FDA-approved product — while Hims supplies FDA-approved drugs only. That is a difference in what arrives, not only in what it costs.
- Which one has more regulatory actions on record?
- Hims, with 5 sourced actions against 2 actions for Henry Meds. Every one is linked to its primary document on the provider's own page. A larger file is not automatically a worse company — read what the documents actually say.
Other comparisons: Hims vs Ro (Ro Body) · Hims vs Hers · Hims vs LillyDirect · Henry Meds vs Willow · Henry Meds vs MEDVi